S-1: Presurance Holdings Launches $14M Rights Offering

Presurance Holdings, Inc. is conducting a non-transferable subscription rights offering to raise up to $14 million by selling 14,000,000 shares of common stock at $1.00 per share.

Summary

• Presurance Holdings, Inc. is distributing non-transferable subscription rights to purchase up to 14,000,000 shares of common stock at a subscription price of $1.00 per share.
• The offering aims to raise approximately $14 million in gross proceeds, before expenses, which will be used to redeem all or a portion of Series B Preferred Stock and for general corporate purposes.
• The subscription price of $1.00 per share is significantly higher than the closing sales price of $0.65 per share for common stock on January 13, 2026.
• Clarkston Companies, Inc., an entity affiliated with director Jeffrey Hakala, has committed to a backstop agreement to purchase any unsubscribed shares, ensuring the full $14 million capital raise objective is met.
• The company's business model shifted from MGA and wholesale agency operations to an underwriting-based revenue model following the August 2024 sale of Conifer Insurance Services and Sycamore Specialty Underwriters, LLC.
• As of September 30, 2025, the company primarily writes specialty homeowners business in Texas, Illinois, and Indiana, with historical commercial business largely in run-off.
• The board of directors is making no recommendation regarding the exercise of the subscription rights, urging shareholders to make their own assessment.
• All exercises of subscription rights are irrevocable, with limited exceptions for fundamental changes to the offering terms or extensions exceeding 30 days.

Sentiment

Score: 3

Explanation: While the capital raise is secured by a backstop agreement, the terms are unfavorable to existing shareholders (subscription price significantly above market price), and the company faces substantial financial challenges including adverse reserve development, a reinsurer default leading to significant write-offs, and uncertainty regarding a large contingent payment. The high dilution risk and related-party control contribute to a negative outlook.

Positives

• The rights offering is expected to secure up to $14 million in gross proceeds, providing crucial liquidity for the company.
• A backstop agreement with Clarkston Companies, Inc. ensures the full capital raise objective is met, mitigating subscription risk.
• Proceeds will be used to redeem all or a portion of the Series B Preferred Stock, which carries a high annualized dividend rate of 13.0% as of December 31, 2025, potentially reducing debt service costs.
• The offering structure allows all existing shareholders to participate on a pro rata basis, maintaining their ownership percentage if they fully subscribe.

Negatives

• The subscription price of $1.00 per share is substantially higher than the market closing price of $0.65 per share on January 13, 2026, implying an immediate unrealized loss for subscribers.
• Shareholders who do not fully exercise their subscription rights will experience significant dilution of their ownership interest.
• The subscription rights are non-transferable, preventing shareholders from selling them to realize any potential value.
• The company faces a likely write-off of $2.0 million to $4.4 million of Loss Portfolio Transfer (LPT) recoverables due to a reinsurer's failure to fund a $4.4 million collateral shortfall and subsequent provisional liquidation.
• A preliminary assessment indicates an expected increase in reserve estimates for additional adverse development of up to potentially $5.0 million at December 31, 2025.
• There is uncertainty regarding the receipt of $6.3 million in contingent consideration from the sale of CIS, which would reduce assets and shareholders' equity if not received.
• If the rights offering is not completed, the company may lack sufficient liquidity to repay the $7.5 million Series B Preferred Stock due December 31, 2026.
• The announcement and completion of the rights offering, along with the issuance of new shares, may cause the market price of common stock to decrease.
• Clarkston Ventures, LLC and its affiliates, who already hold significant voting power (42.1%), may increase their beneficial ownership, potentially leading to interests that differ from other shareholders.
• The company has never paid dividends on its common stock and does not anticipate doing so in the foreseeable future.
• The tax treatment of the rights offering is somewhat uncertain and may be treated as a taxable event for U.S. federal income tax purposes.
• The rights offering could impair or limit the company's net operating loss carryforwards, which were approximately $65 million as of December 31, 2024.

Risks

• Actual incurred losses may be greater than loss and loss adjustment expense reserves, which could have a material adverse effect on financial condition and results of operations.
• Underestimation of claim costs due to changes in actuarial projections, claims handling procedures, inflation, severe weather, climate change, economic and judicial trends, and legislative changes.
• Anticipated reinsurance recoverables on reserves could be negatively impacted by contractual limits of coverage and the financial condition of reinsurers, as evidenced by the $4.4 million collateral shortfall from a reinsurer.
• Preliminary assessment of up to $5.0 million increase in reserve estimates for adverse development at December 31, 2025, could be higher or lower.
• The $6.3 million contingent consideration from the sale of CIS may not be received, reducing anticipated future liquidity, assets, and shareholders' equity.
• Failure to complete the rights offering may result in insufficient liquidity to repay the $7.5 million Series B Preferred Stock due within the next twelve months.
• The market price of common stock is volatile and may decline before or after the subscription rights expire, potentially leading to immediate unrealized losses for subscribers.
• Inability to sell common stock purchased in the rights offering at a price equal to or greater than the subscription price.
• Dilution of ownership interest for shareholders who do not fully exercise their subscription rights.
• The subscription rights are non-transferable, meaning there is no market to directly realize their value.
• The subscription price of $1.00 per share is not necessarily an indication of the fair value of common stock.
• Management will have broad discretion over the use of proceeds, and investments may not yield a favorable return.
• The company may cancel, amend, or modify the rights offering at any time prior to expiration.
• There is no guarantee that the transaction contemplated by the Backstop Agreement will be consummated in a timely manner.
• Subscription exercises are irrevocable, even if the rights offering is extended, unless fundamental changes are made or extensions exceed 30 days.
• Failure to act promptly and follow subscription instructions may result in rejection of subscription rights.
• The tax treatment of the rights offering is somewhat uncertain and may be treated as a taxable event for U.S. federal income tax purposes.
• The rights offering could impair or limit the company's net operating loss carryforwards (approximately $65 million as of December 31, 2024).
• The rights offering may cause the price of common stock to decrease.
• No interest will be received on subscription funds held by the subscription agent.
• Clarkston Ventures, LLC and its affiliates have significant influence (42.1% voting power) and their increased ownership could delay, deter, or prevent a change of control or adversely affect the stock price.
• Provisions in the articles of incorporation, bylaws, and Michigan law could make it more difficult for a third party to acquire the company or discourage a takeover.

Future Outlook

The company intends to use the net proceeds from the rights offering to redeem all or a portion of its Series B Preferred Stock and for general corporate purposes, aiming to strengthen its financial condition and provide sufficient liquidity through December 31, 2026. Management believes the rights offering is a cost-effective way to raise capital and allows all shareholders to participate. However, the company expects to increase its reserve estimates for additional adverse development by up to potentially $5.0 million at December 31, 2025, and faces uncertainty regarding the receipt of $6.3 million in contingent consideration and the recoverability of $2.0 million to $4.4 million in LPT recoverables. The company does not anticipate paying dividends on common stock in the foreseeable future.

Management Comments

• "Our board of directors has approved the rights offering as a cost-effective manner of raising capital that allows all shareholders to participate."
• "Our objective is to raise the full $14 million in gross proceeds from our rights offering."
• "We have therefore obtained a commitment from the Backstop Purchasers in order to establish a higher likelihood of receiving the full amount of our rights offering objective."
• "Our board of directors is making no recommendation regarding your exercise of the subscription rights. You are urged to make your decision based on your own assessment of our business and the rights offering."
• "We believe, and intend to take the position, that the rights offering should not be part of a disproportionate distribution of our stock, but certain aspects of that determination are unclear."
• "We currently intend to retain earnings, if any, to support our growth strategy. We do not anticipate paying dividends on our common stock in the foreseeable future."

Industry Context

The company has strategically shifted its business model from MGA and wholesale agency operations to an underwriting-based revenue model, focusing on niche specialty homeowners business. This pivot suggests an effort to streamline operations and concentrate on core underwriting profitability, although it also highlights the run-off nature of its historical commercial lines. The challenges with adverse loss reserve development and the default of a reinsurer are significant risks inherent in the property and casualty insurance industry, particularly for companies managing long-tail liabilities. The necessity for a capital raise, even with a backstop, indicates financial pressure, which can be exacerbated by competitive market conditions and rising claims costs within the insurance sector.

Corporate Governance

Legal Proceedings

• On December 12, 2025, the Supreme Court of Bermuda Commercial Companies appointed joint provisional liquidators to the reinsurer providing the company's loss portfolio transfer (LPT), indicating significant financial distress for the reinsurer and potential non-recoverability of reinsurance assets.

Related Party Transactions

• On December 23, 2025, the company sold 1,600 shares of Series C Preferred Stock for $8,000,000 to Clarkston Companies, Inc., an entity affiliated with Jeffrey Hakala, a member of the Board of Directors.
• Clarkston Companies, Inc. and certain affiliates (Backstop Purchasers) intend to enter into a Rights Offering Backstop Agreement to purchase any unsubscribed shares in the offering.
• As of January 14, 2026, Clarkston Ventures, LLC (affiliated with Jeffrey Hakala and Gerald Hakala) beneficially owned approximately 30.6% of the outstanding common stock and, together with its affiliates, held rights to vote 42.1% of the outstanding voting shares.
• The Series B Preferred Stock was initially sold to Clarkston 91 West LLC (affiliated with Gerald and Jeffrey Hakala) and subsequently sold to Clarkston Companies, Inc.

Stakeholder Impact

• **Shareholders**: Non-participating shareholders will experience significant dilution. Participating shareholders will acquire shares at a premium to the current market price. The increased ownership and influence of Clarkston Ventures and its affiliates may lead to decisions that do not align with the interests of other shareholders.
• **Creditors**: The use of proceeds to redeem Series B Preferred Stock could improve the company's debt profile and financial stability, potentially benefiting other creditors.
• **Employees**: No direct impact is explicitly mentioned, but improved financial stability from the capital raise could indirectly benefit employees by securing the company's operations.
• **Customers**: The strategic shift to an underwriting-based model and focus on specialty homeowners business may affect product offerings and service in the long term, but no immediate direct impact is detailed.

Next Steps

• Completion of the rights offering and issuance of new common stock shares to subscribers.
• Redemption of all or a portion of Series B Preferred Stock using the net proceeds from the offering.
• Finalization of reserve estimates with an opining actuary for the December 31, 2025, financial statements, to be reported in the Annual Report on Form 10-K in March 2026.
• Monitoring of the reinsurer's liquidation process and the recoverability of LPT assets.

Key Dates

Recommendation

The rights offering is highly dilutive for non-participating shareholders and offers shares at a significant premium ($1.00) to the current market price ($0.65), indicating an immediate loss for those who subscribe. The company faces substantial financial headwinds, including adverse loss reserve development, a reinsurer default leading to significant write-offs, and uncertainty regarding a large contingent payment. While the capital raise is secured by a backstop, the underlying business challenges and the unfavorable terms of the offering suggest further downside risk for the common stock. The significant control by related parties also raises governance concerns for minority shareholders.

Keywords

Rights Offering, Capital Raise, Presurance Holdings, PRHI, Common Stock, Dilution, Preferred Stock Redemption, Insurance, Loss Reserves, Backstop Agreement, Nasdaq Capital Market, Corporate Governance, SEC Filing, Underwriting, Specialty Insurance